Late breaking trials at R4P
Wednesday, January 27, 2021
•
HY01
•
3:00 PM
>
4:00 PM
•
Late breaking trials at R4P
•
Live channel 2
This session will review the efficacy data from the two latest clinical trials recently completed, namely the HPTN 084 (Life) and the Antibody Mediated Prevention (AMP) trials. This will be followed by a moderated panel discussion to review the implications for prevention and for HIV globally.
3:00 PM
•
HY01.01LB
•
VRC01 antibody prevention of HIV
See abstract
3:15 PM
•
HY01.02
•
Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084
See abstract
3:30 PM
•
HY01.03
•
Panel discussion
See abstract
|